Coral Laboratories Limited (BOM:524506)
688.65
+21.50 (3.22%)
At close: Apr 17, 2025
Coral Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Cash & Equivalents | - | 20.71 | 61.3 | 25.06 | 23.25 | 11.12 | Upgrade
|
Short-Term Investments | - | 13.23 | 12.39 | 21.19 | 0.96 | - | Upgrade
|
Trading Asset Securities | - | 243.92 | 226.41 | 196.4 | 189.86 | - | Upgrade
|
Cash & Short-Term Investments | 912.56 | 277.87 | 300.1 | 242.65 | 214.07 | 11.12 | Upgrade
|
Cash Growth | 14.94% | -7.41% | 23.67% | 13.35% | 1825.58% | -62.55% | Upgrade
|
Accounts Receivable | - | 281.93 | 234.21 | 381.14 | 391.6 | 344.08 | Upgrade
|
Other Receivables | - | - | - | 0.06 | 0.05 | - | Upgrade
|
Receivables | - | 283.88 | 236.23 | 382.74 | 398.24 | 448.89 | Upgrade
|
Inventory | - | 151.57 | 125.04 | 183.62 | 216.75 | 192.99 | Upgrade
|
Prepaid Expenses | - | 0.87 | 0.86 | 1.97 | 1.19 | 4.34 | Upgrade
|
Other Current Assets | - | 824.36 | 573.17 | 497.06 | 455.97 | 301 | Upgrade
|
Total Current Assets | - | 1,539 | 1,235 | 1,308 | 1,286 | 958.34 | Upgrade
|
Property, Plant & Equipment | - | 232.74 | 242.82 | 244.94 | 209.08 | 214.91 | Upgrade
|
Long-Term Investments | - | 240.35 | 174.09 | 244.25 | 140.96 | 248.73 | Upgrade
|
Other Intangible Assets | - | 0.63 | 0.18 | 0.19 | 0.25 | 0.43 | Upgrade
|
Other Long-Term Assets | - | 41.04 | 87.46 | 98.04 | 35.4 | 10.3 | Upgrade
|
Total Assets | - | 2,057 | 1,743 | 1,899 | 1,675 | 1,443 | Upgrade
|
Accounts Payable | - | 132.4 | 42.12 | 87.98 | 147.75 | 141.44 | Upgrade
|
Accrued Expenses | - | 13.66 | 18.72 | 13.65 | 10.87 | 7.34 | Upgrade
|
Short-Term Debt | - | - | - | 60.39 | 62.54 | 59.13 | Upgrade
|
Current Income Taxes Payable | - | 49.09 | 18.2 | 27.5 | 25.82 | 15.28 | Upgrade
|
Current Unearned Revenue | - | - | - | - | - | 22.93 | Upgrade
|
Other Current Liabilities | - | 53.84 | 39.57 | 65.66 | 28.66 | 4.75 | Upgrade
|
Total Current Liabilities | - | 248.99 | 118.6 | 255.18 | 275.65 | 250.86 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 25.7 | 25.36 | 25.75 | 25.15 | 29.57 | Upgrade
|
Other Long-Term Liabilities | - | 3.34 | 48.05 | 54.06 | 4.5 | 2.29 | Upgrade
|
Total Liabilities | - | 281.84 | 195.47 | 338.43 | 308.96 | 286.15 | Upgrade
|
Common Stock | - | 35.73 | 35.73 | 35.73 | 35.73 | 35.73 | Upgrade
|
Retained Earnings | - | 1,517 | 1,359 | 1,294 | 1,204 | 1,068 | Upgrade
|
Comprehensive Income & Other | - | 222.57 | 153.48 | 230.48 | 126.84 | 52.66 | Upgrade
|
Shareholders' Equity | 2,035 | 1,775 | 1,548 | 1,561 | 1,366 | 1,157 | Upgrade
|
Total Liabilities & Equity | - | 2,057 | 1,743 | 1,899 | 1,675 | 1,443 | Upgrade
|
Total Debt | - | - | - | 60.39 | 62.54 | 59.13 | Upgrade
|
Net Cash (Debt) | 912.56 | 277.87 | 300.1 | 182.26 | 151.53 | -48.01 | Upgrade
|
Net Cash Growth | 17.10% | -7.41% | 64.66% | 20.28% | - | - | Upgrade
|
Net Cash Per Share | 255.41 | 77.78 | 84.00 | 51.02 | 42.41 | -13.44 | Upgrade
|
Filing Date Shares Outstanding | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | Upgrade
|
Total Common Shares Outstanding | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | Upgrade
|
Working Capital | - | 1,290 | 1,117 | 1,053 | 1,011 | 707.48 | Upgrade
|
Book Value Per Share | 569.82 | 496.83 | 433.29 | 436.81 | 382.48 | 323.77 | Upgrade
|
Tangible Book Value | 2,035 | 1,774 | 1,548 | 1,560 | 1,366 | 1,156 | Upgrade
|
Tangible Book Value Per Share | 569.65 | 496.65 | 433.24 | 436.75 | 382.40 | 323.65 | Upgrade
|
Land | - | - | - | - | - | 9.17 | Upgrade
|
Buildings | - | 136.22 | 135.97 | 123.22 | 122.67 | 113.05 | Upgrade
|
Machinery | - | 362.81 | 355.02 | 331.99 | 289.31 | 280.38 | Upgrade
|
Construction In Progress | - | - | - | 17.22 | 5.02 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.